COMP <GO>
BMGL vs PIII // EV/EBITDA & P/E VALUATION
Basel Medical Group Ltd (NASDAQ) VS. P3 Health Partners Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: BMGL 2
— PIII 0
■ METRIC PARITY
LAST: $4.75 (+3.26%) • MKT CAP: $36.0M
valuation
—
LAST: $4.20 (+4.22%) • MKT CAP: $30.5M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BMGL VS. PIII)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BMGL | PIII | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -18.50% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -10.10% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -2.80% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 1/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.5 | 32.2 | +35.26 | BMGL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $36.0M | $30.5M | $5.5M | BMGL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BMGL REV | PIII REV | BMGL GROSS % | PIII GROSS % | BMGL FCF | PIII FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $1.46B | — | — | — | -$91.2M |
| FY 2024 | — | $1.50B | — | — | — | -$110.1M |
| FY 2023 | — | $1.27B | — | — | — | -$76.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BMGL // BETA —
PIII // BETA —